Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran operating margin
Operating margin is operating income as a percentage of revenue.
Bioxytran's operating margin for the twelve months ending Jun 30, 2018 was -20.5%. For fiscal 2017 it was -162.5%, against -272.3% the year before. The highest annual figure on record is -162.5% in fiscal 2017.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | -162.5% | +109.8 |
| FY2016 | Dec 31, 2016 | -272.3% | +545.6 |
| FY2015 | Dec 31, 2015 | -817.9% | −353.2 |
| FY2014 | Dec 31, 2014 | -464.7% | +8.0 |
| FY2013 | Dec 31, 2013 | -472.6% | +259.1 |
| FY2012 | Dec 31, 2012 | -731.8% | +5071.8 |
| FY2011 | Dec 31, 2011 | -5803.6% | −3763.9 |
| FY2010 | Dec 31, 2010 | -2039.6% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | -1.4% | +653.5 |
| Q1 FY2018 | Mar 31, 2018 | -5.0% | +837.3 |
| Q4 FY2017 | Dec 31, 2017 | -268.4% | −504.2 |
| Q3 FY2017 | Sep 30, 2017 | 45.4% | +255.0 |
| Q2 FY2017 | Jun 30, 2017 | -654.8% | – |
| Q1 FY2017 | Mar 31, 2017 | -842.3% | – |
| Q4 FY2016 | Dec 31, 2016 | 235.8% | – |
| Q3 FY2016 | Sep 30, 2016 | -209.6% | – |
See a number that looks wrong?